Abstract
INVITRO EVALUATION OF GEMCITABINE AND ITS DERIVATIVE (GEMCITABINE ELAIDATE) FOR THE TREATMENT OF PANCREATIC CANCER
Dr. Syed Ahmed Hussain*, Shaik Nazma Sultana, Sara Umm E. Hani, Farahanaaz Begum and Juveria Gaffar
ABSTRACT
This research paper examines the cellular impact of Gemcitabine Elaidate on cellular viability, tubulogenesis, and protein expression levels using MTT assay, Tubulogenesis assay, Indirect Immunofluorescence assay, and Western Blot analysis. The study involves four treatment groups: Group 1 (normal), Group 2 (Control cell line), Group 3 (Standard GEMCITABINE), and Group 4 (Gemcitabine Elaidate). The results suggest that Gemcitabine Elaidate significantly affects cellular viability and tubulogenesis when compared to standard GEMCITABINE treatment. These findings highlight the potential impact of Gemcitabine Elaidate on cellular processes and call for further investigation.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST PAPER AWARDS
World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .
Best Article of current issue
Download Article : Click here